Switzerland · 
How much has ReproNovo raised?
ReproNovo has raised $65M across 1 round since 2025.
Switzerland · Series A startup
Who invested in ReproNovo
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow ReproNovo and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$65Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $65MMay 2025
- Investors
- 0
The rounds
- May 2025Series A$65M
No investor was named in the report.
Source recorded
Founders and team
From ReproNovo's own website: 11 on the team.
- Jean Marie DuvallChief Executive Officer
- Brenda MarcziSenior Vice President, Regulatory Affairs
- Bingmei HaoChief Financial Officer
- Heidi AastedHead of Global Clinical Operations
- Lisbeth HelmgaardHead of Global Medical Writing & Biometrics
- Lasse ÖznekCMC Project Director
- Lenka ZemanovaClinical Project Manager
- Lise Laurbjerg NielsenSenior Regulatory Affairs Lead
- Mark AltmeyerChairman of the Board
- Trine Skjærbæk ChristiansenSenior Clinical Project Manager
- Virginia EstellerSenior Principal Medical Writer
Also claim to have backed them
This firm lists ReproNovo as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about ReproNovo
When did ReproNovo last raise?
ReproNovo's most recent round was a Series A of $65M in May 2025.
What was ReproNovo's biggest round?
Its most recent round, $65M in May 2025, is also its largest on record.
What stage is ReproNovo at?
ReproNovo's latest named round is a Series A, in May 2025.
Where is ReproNovo based?
ReproNovo is based in Switzerland.
Companies like ReproNovo
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.